Background & Aims
The aim of this study was to evaluate the nutritional support management in mechanically ventilated coronavirus disease 2019 (COVID-19) patients and explore the association between early caloric deficit and mortality, taking possible confounders (i.e. obesity) into consideration.
Methods
This was a prospective study carried out during the first pandemic wave in the intensive care units (ICUs) of two referral University Hospitals in Lombardy, Italy.
Two hundred twenty-two consecutive mechanically ventilated COVID-19 patients were evaluated during the ICU stay. In addition to major demographic and clinical data, we recorded information on the route and amount of nutritional support provided on a daily basis.
Results
Among patients still in the ICUs and alive on day 4 (N=198), 129 (65.2%) and 72 (36.4%) reached a satisfactory caloric and protein intake, respectively, mainly by enteral route.
In multivariable analysis, a satisfactory caloric intake on day 4 was associated with lower mortality (HR=0.46 [95%CI, 0.42-0.50], P<0.001). Mild obesity (body mass index [BMI] ≥30 and <35 kg/m
2
) was associated with higher mortality (HR=1.99 [95%CI, 1.07-3.68], P=0.029), while patients with moderate-severe obesity (BMI≥35 kg/m
2
) were less likely to be weaned from invasive mechanical ventilation (HR=0.71 [95%CI, 0.62-0.82], P<0.001).
Conclusions
This study confirmed the negative prognostic and clinical role of obesity in mechanically ventilated COVID-19 patients and suggested that early caloric deficit may independently contribute to worsen survival in this patients’ population. Therefore, any effort should be made to implement an adequate timely nutritional support in all COVID-19 patients during the ICU stay.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.